Wells Fargo upgrades Celanese stock rating on cost savings potential

Wells Fargo upgraded Celanese (CE) to Overweight with a price target of $66, citing potential for sequential EPS improvement driven by cost savings and reduced maintenance, despite no anticipated near-term demand improvement. The upgrade aligns with upward earnings revisions from eight analysts and the company's expected return to profitability this year. This follows Celanese's Q1 2025 earnings beat, with EPS at $0.57 versus the $0.39 forecast, and revenue exceeding projections at $2.4 billion, prompting KeyBanc and BMO Capital Markets to also raise their price targets and ratings, respectively.

Analysis

Celanese (NYSE:CE) has received a significant vote of confidence from Wells Fargo, which upgraded the stock to Overweight from Equal Weight and substantially raised its price target to $66.00 from $45.00. This optimism is rooted in expectations of sequential earnings per share improvement, driven by anticipated cost savings and reduced maintenance requirements, even without assuming near-term demand improvement for the materials company. This upgrade aligns with broader positive sentiment, as evidenced by eight analysts recently revising their earnings estimates upward for Celanese, with the company projected to return to profitability this year. The stock, which had declined approximately 70% from its April 3, 2024 high, currently trades at 7.5 times a mid-cycle EBITDA of $2.5 billion; Wells Fargo's new target implies a valuation of approximately 9.5 times expected 2025 EV/EBITDA. Further supporting this positive outlook, Celanese reported Q1 2025 earnings per share of $0.57, significantly beating the $0.39 forecast, and revenues of $2.4 billion, surpassing the anticipated $2.26 billion. This performance prompted KeyBanc Capital Markets to raise its price target to $76.00, maintaining an Overweight rating, citing the end of automotive inventory reductions and steady demand in other key sectors. BMO Capital Markets also upgraded Celanese to "Market Perform" from "Underperform," increasing its price target to $55.00, due to a more balanced risk-reward profile from easing tariff concerns and potential asset sales. Corporate governance enhancements, such as the removal of supermajority voting requirements, have also been implemented following shareholder approval. Celanese, with a market capitalization of $5.98 billion and annual revenue of $10.06 billion, is actively pursuing strategic initiatives like divestitures and cost control measures to bolster its financial health.

Key Decisions for Investors

• Investors should consider the recent confluence of analyst upgrades, particularly Wells Fargo's significant price target increase to $66, and Celanese's strong Q1 2025 earnings beat as potential catalysts for a stock re-rating, especially given its prior substantial underperformance.
• Evaluate Celanese's valuation, currently at 7.5 times mid-cycle EBITDA, in the context of improved profitability prospects driven by internal cost-saving measures and reduced maintenance, which analysts believe can occur even without immediate broad market demand recovery.
• Monitor the execution of Celanese's strategic initiatives, including cost controls, divestitures, and the impact of governance changes, as these are critical for achieving projected earnings improvements and navigating ongoing market challenges.